Anne Tybjærg-Hansen

Anne Tybjærg-Hansen

Clinical Professor

Member of:

  • Clinical Biochemistry


Publication year:
All
1 - 10 out of 22Page size: 10
Sort by: Title
  1. Published

    Visible aging signs as risk markers for ischemic heart disease: Epidemiology, pathogenesis and clinical implications

    Christoffersen, M. & Tybjærg-Hansen, Anne, Jan 2016, In: Ageing Research Reviews. 25, p. 24-41 18 p.

    Research output: Contribution to journal › Review › Research › peer-review

  2. Published

    Using human genetics to predict the effects and side-effects of drugs

    Stender, S. & Tybjærg-Hansen, Anne, Apr 2016, In: Current Opinion in Lipidology. 27, 2, p. 105-111 7 p.

    Research output: Contribution to journal › Review › Research › peer-review

  3. Published

    Using Human Genetics to Predict the Effects and Side Effects of Lipoprotein(a) Lowering Drugs

    Tybjærg-Hansen, Anne, Dec 2016, In: Journal of the American College of Cardiology. 68, 25, p. 2773-2775 3 p.

    Research output: Contribution to journal › Comment/debate › Research

  4. Published

    The Sialylation Pathway and Coronary Artery Disease

    Tybjærg-Hansen, Anne, 2 Jun 2016, In: New England Journal of Medicine. 374, 22, p. 2169-2171 3 p.

    Research output: Contribution to journal › Editorial › Research

  5. Published

    Sex Hormones and Ischemic Stroke: A Prospective Cohort Study and Meta-Analyses

    Holmegard, H. N., Nordestgaard, Børge, Jensen, G. B., Tybjærg-Hansen, Anne & Benn, Marianne, Jan 2016, In: The Journal of Clinical Endocrinology & Metabolism. 101, 1, p. 69-78 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Response to the Letter: Response to "Use of biomarkers to identify new drug targets and to predict risk of cardiometabolic outcomes" by Abasi A., et al

    Holmegard, H. N., Nordestgaard, Børge, Jensen, G. B., Tybjærg-Hansen, Anne & Benn, Marianne, Feb 2016, In: The Journal of clinical endocrinology and metabolism. 101, 2, p. L22-L23

    Research output: Contribution to journal › Letter › Research › peer-review

  7. Published

    Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease

    CHD Exome+ Consortium, C. E. C., CARDIoGRAM Exome Consortium, C. E. C. & Global Lipids Genetics Consortium, G. L. G. C., 11 Mar 2016, In: Science (New York, N.Y.). 351, 6278, p. 1166-71 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population

    Rasmussen, K. L., Tybjærg-Hansen, Anne, Nordestgaard, Børge & Frikke-Schmidt, Ruth, Mar 2016, In: Atherosclerosis. 246, p. 63-70 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis

    Langsted, A., Nordestgaard, Børge, Benn, Marianne, Tybjærg-Hansen, Anne & Kamstrup, P. R., Sep 2016, In: The Journal of clinical endocrinology and metabolism. 101, 9, p. 3281-3287 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217

    Benn, M., Watts, G. F., Tybjærg-Hansen, Anne & Nordestgaard, Børge, 1 May 2016, In: European Heart Journal. 37, 17, p. 1384-94 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 Next

ID: 924951